文献速递心律失常

心电图与电生理检查对1型强直性肌营养不良主要传导延迟的预测比较

Electrocardiogram vs Electrophysiological Study and Major Conduction Delays in Myotonic Dystrophy Type 1.
PubMed 文献 · JAMA Cardiol · 2025-01-01

该队列分析纳入706例遗传确诊的1型强直性肌营养不良成人,比较心电图与电生理检查策略对主要缓慢性心律失常事件的预测效能。中位随访5.9年,99例(14%)发生主要缓慢性心律失常事件,HV间期是唯一显著相关变量,EPS标准较心电图标准更可靠、更敏感,HV阈值降至65毫秒可进一步提高敏感性。

要点

  • HV间期是主要缓慢性心律失常事件的独立预测因子(HR 1.77)。
  • EPS标准预测效能优于心电图标准(HR 2.89 vs 1.95)。
  • HV阈值降至65毫秒可提高敏感性至90.18%。

核心结论

  • 在1型强直性肌营养不良患者中,HV间期预测主要缓慢性心律失常事件优于心电图标准。
  • HV阈值大于等于65毫秒可能改善预防性起搏的风险分层。

研究设计与样本

  • 回顾性队列分析,数据来自DM1心脏登记,纳入2000至2020年6家法国大学医院遗传确诊的成人DM1患者。
  • 共纳入706例患者(平均年龄42岁,男性51%),均有1999年后首次电生理检查史且无晚期房室阻滞或持续性室速病史。

主要发现

  • 基线时273例(38%)HV间期大于等于70毫秒,232例(32%)符合心电图标准。
  • 中位随访5.9年,99例(14%)发生主要缓慢性心律失常事件。
  • 多变量Cox和联合模型中,HV间期是唯一与主要缓慢性心律失常事件 incidence 显著相关的变量(HR 1.77; 95%CI 1.46-2.16; P<.001 和 HR 1.78; 95%CI 1.40-2.22; P=.001)。
  • EPS标准较心电图标准更可靠(HR 2.89; 95%CI 1.92-4.34 vs HR 1.95; 95%CI 1.31-2.89)且更敏感(性能指数SE 68.35%[6.24%] vs 34.76%[6.47%])。
  • HV阈值降至大于等于65毫秒进一步改善敏感性(性能指数SE 90.18%[3.85%])和净重分类改善(33.7%; 95%CI 19.6%-48.2%)。

关键数值与推荐

  • 现行指南推荐无症状患者PR间期大于等于240毫秒和/或QRS时限大于等于120毫秒,或电生理检查HV间期大于等于70毫秒时植入起搏器(IIa类指征)。
  • 本研究中HV间期大于等于70毫秒预测主要缓慢性心律失常事件的HR为2.89(95%CI 1.92-4.34)。
  • HV间期大于等于65毫秒预测主要缓慢性心律失常事件的敏感性为90.18%(3.85%),净重分类改善33.7%(95%CI 19.6%-48.2%)。

临床怎么用

  • 对于遗传确诊的1型强直性肌营养不良成人,可考虑用电生理检查HV间期评估主要缓慢性心律失常事件风险。
  • HV间期大于等于65毫秒可能作为预防性起搏的更敏感风险分层阈值。

局限性

  • 回顾性队列分析,数据来自登记研究,可能存在选择偏倚和信息偏倚。
  • 结果需在前瞻性研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: For the prevention of sudden cardiac death in myotonic dystrophy type 1 (dystrophia myotonica; DM1), professional practice guidelines recommend pacemaker implantation in asymptomatic patients with a PR interval greater than or equal to 240 milliseconds and/or QRS duration greater than or equal to 120 milliseconds on electrocardiogram (ECG), or a His-ventricular (HV) interval greater than or equal to 70 milliseconds during electrophysiological study (EPS), as class IIa indications. OBJECTIVE: To determine which of these strategies-ECG or EPS based-is more effective in predicting major bradyarrhythmic events (MBAEs). DESIGN, SETTING, AND PARTICIPANTS: This was a cohort analysis of retrospectively collected longitudinal data from the DM1 Heart Registry. The setting included cardiology and neurology departments of 6 French university hospitals. Study participants were selected from individuals enrolled in the DM1 Heart Registry between 2000 and 2020. The DM1 Heart Registry includes adults with genetically confirmed DM1. Included patients had a history of first EPS after 1999 and no personal history of advanced atrioventricular block or sustained ventricular tachycardia. Study data were analyzed from January to July 2025. EXPOSURES: ECG- and EPS-based strategies. MAIN OUTCOMES AND MEASURES: The primary outcome was MBAEs, defined as sudden cardiac death, resuscitated cardiac arrest, or second-degree type II or complete atrioventricular block. RESULTS: Of 1778 adults with genetically confirmed DM1 enrolled in the DM1 Heart Registry, a total of 706 patients (mean [SD] age, 42 [13] years; 359 male [51%]) were included in this study. At baseline, 273 patients (38%) had an HV interval greater than or equal to 70 milliseconds, and 232 (32%) met ECG criteria. Over a median (IQR) follow-up of 5.9 (2.3-9.7) years, 99 patients (14%) experienced an MBAE. In multivariable Cox and joint models incorporating baseline and time-varying values of PR and QRS durations, the HV interval was the only variable significantly associated with the incidence of MBAEs (hazard ratio [HR], 1.77; 95% CI, 1.46-2.16; P < .001 and HR, 1.78; 95% CI, 1.40-2.22; P = .001, respectively). Compared with ECG-based criteria, the EPS criterion proved to be a more reliable (HR, 2.89; 95% CI, 1.92-4.34 vs HR, 1.95; 95% CI, 1.31-2.89) and more sensitive (performance index [SE], 68.35% [6.24%] vs 34.76% [6.47%]) predictor of MBAE and accurately reclassified 28.8% of patients with an MBAE. Lowering the threshold to HV greater than or equal to 65 milliseconds further improved sensitivity (performance index [SE], 90.18% [3.85%]) and net reclassification improvement (33.7%; 95% CI, 19.6%-48.2%) for MBAE prediction. CONCLUSIONS AND RELEVANCE: In this cohort of patients with DM1, the HV interval outperformed ECG criteria in predicting MBAEs. An HV threshold greater than or equal to 65 milliseconds may enhance risk stratification for prophylactic pacing.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Clementy N, Labombarda F, Grolleau F, et al. Electrocardiogram vs Electrophysiological Study and Major Conduction Delays in Myotonic Dystrophy Type 1. JAMA Cardiol. 2025. PMID: 40991257. doi:10.1001/jamacardio.2025.3055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。